WO2000046597A1 - Dissolution test sample holder - Google Patents

Dissolution test sample holder Download PDF

Info

Publication number
WO2000046597A1
WO2000046597A1 PCT/US2000/003003 US0003003W WO0046597A1 WO 2000046597 A1 WO2000046597 A1 WO 2000046597A1 US 0003003 W US0003003 W US 0003003W WO 0046597 A1 WO0046597 A1 WO 0046597A1
Authority
WO
WIPO (PCT)
Prior art keywords
test sample
membrane
end cap
ring
dissolution
Prior art date
Application number
PCT/US2000/003003
Other languages
French (fr)
Other versions
WO2000046597A9 (en
Inventor
Kenneth M. Feld
Donna M. Heren
Cynthia M. Ciliberto
Original Assignee
Dermik Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dermik Laboratories, Inc. filed Critical Dermik Laboratories, Inc.
Priority to AU38562/00A priority Critical patent/AU3856200A/en
Priority to US09/890,484 priority patent/US6929782B1/en
Publication of WO2000046597A1 publication Critical patent/WO2000046597A1/en
Publication of WO2000046597A9 publication Critical patent/WO2000046597A9/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/18Apparatus therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N13/00Investigating surface or boundary effects, e.g. wetting power; Investigating diffusion effects; Analysing materials by determining surface, boundary, or diffusion effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N13/00Investigating surface or boundary effects, e.g. wetting power; Investigating diffusion effects; Analysing materials by determining surface, boundary, or diffusion effects
    • G01N2013/006Dissolution of tablets or the like

Definitions

  • This invention is a device for holding a test sample during dissolution and/or release testing and is especially suited for holding viscous topical formulations used for transdermal and dermal drug delivery.
  • Topical formulations including ointments, creams, lotions, pastes, oils and gels, are used in the dermal and transdermal (through the skin) delivery of active drugs such as, for example, hydrocortisone and nitroglycerin to sites of action in the body.
  • active drugs such as, for example, hydrocortisone and nitroglycerin
  • Topical application of a drug is advantageous because it allows localized delivery of the therapeutic agent directly to the desired site, thus, increasing bioavailability (the extent to which a drug reaches its site of action) , reducing drug side effects and loss of therapeutic efficiency and increasing patient compliance.
  • a sample of the formulation be it a cream, lotion, ointment, gel or other medium containing the drug or active agent
  • a permeable membrane which simulates the barrier, presented by the skin, between the drug and the site of action.
  • the membrane could be formed from actual skin taken from a laboratory animal, or a synthetic material such as polysulfone, acrylic polymer, glass fiber or PTFE to cite a few examples.
  • the side of the membrane opposite the test sample is brought into contact with a liquid receptor media, and the drug or other active agent in the formulation diffuses through the membrane and dissolves into the receptor media.
  • the concentration of the drug in the receptor media is measured periodically over time to establish the rate at which it is delivered into the media, thus, providing an indication of its delivery rate in actual use.
  • the invention is a dissolution test sample holder immersible within a liquid for measuring the release or dissolution rate of a test sample in the liquid.
  • the test sample is dispensed into the liquid by diffusion through a porous membrane mounted within the holder.
  • the holder is formed by a tubular body having opposed ends, at least one of the ends being open.
  • An end cap is removably attached to the open end.
  • the end cap has a peripheral side wall coaxially interengaged with the body. Frictional forces between the side wall and the body hold the end cap removably to the body. An interference fit between the end cap and the body causes the friction and results in a seal between the side wall and the body.
  • a flange extends substantially perpendicularly inwardly of the side wall and forms a surface within the end cap for supporting the porous membrane, the flange surrounding and defining an aperture through the end cap.
  • the membrane is positionable on the surface and covers the aperture.
  • the test sample is positionable within the end cap on the membrane.
  • the end of the body to which the end cap is attached is immersible to bring the membrane into contact with the liquid, thereby allowing the test sample to diffuse though the porous membrane and dissolve in the liquid.
  • a ring sized to fit coaxially within the end cap.
  • the ring is positioned on top of the membrane, the membrane being sandwiched between the ring and the support surface.
  • the ring has a predetermined thickness and an inner perimeter defining a volume holding the test sample in contact with the membrane.
  • the tubular body and the end cap are cylindrical in shape
  • the aperture is circular and has a predetermined diameter
  • the ring has circular inner and outer perimeters.
  • the ring inner diameter is substantially equal to the diameter of the aperture. This helps confine the test sample to the wetted area of the membrane, thus, ensuring that all of the sample is available for dissolution into the liquid. Varying the ring inner diameter as well as the ring thickness allows the volume of the test sample to be controlled as desired within the size limits of the end cap and body. In order to provide a membrane support surface of practical size, the end cap aperture diameter is smaller than an inner diameter of the body.
  • the test sample holder Due to its construction, the test sample holder according to the invention allows the test sample to be loaded after the holder has been assembled. This provides an opportunity to visually inspect the loaded holder and ensure that the correct amount of sample has been loaded, that there are no air bubbles or other voids in the sample diminishing the membrane wetted surface and that the membrane has not been damaged by the assembly or loading of the holder.
  • a sample cover is used.
  • the sample cover is formed by a disk having a diameter sized to slidingly interfit coaxially within the body and seat on the ring. When seated, the disk covers the test sample held within the inner perimeter of the ring.
  • Agitation is provided by having an opening in the body at the opposite end from the end cap, the opening being sized to accept a rotatable shaft in frictional interengagement .
  • the shaft is coaxial with the body and rotates it with the end cap end immersed within the liquid to promote dissolution of the test sample into the liquid.
  • the invention is used in a method of dissolution and/or release testing of a test sample in a liquid.
  • the method comprises the steps of:
  • end cap removably attachable to one of the ends, the end cap having a peripheral side wall coaxially interengagable with the body and a flange extending substantially perpendicularly inwardly of the side wall and forming a support surface within the end cap, the flange surrounding and defining an aperture through the end cap; (c) providing a porous membrane positionable within the end cap on the support surface and covering the aperture;
  • the method When necessitated by the use of a thin or delicate membrane, the method also includes the steps of:
  • the loading step comprises loading the test sample onto the membrane within the inner perimeter of the ring.
  • test sample holder wherein the test sample can be visually inspected after the holder has been assembled and the test sample has been loaded.
  • test sample holder which can be rotated to provide agitation to promote the dissolution of the test sample. It is again another object of the invention to provide a test sample holder which can be used with standard dissolution equipment and procedures as specified in the United States Pharmacopeia.
  • Figure 1 is an exploded perspective view of a test sample holder according to the invention
  • Figure 2 is a cross sectional side view of the test sample holder shown in Figure 1, the holder being shown assembled and on an enlarged scale;
  • Figure 3 is a side view of the test sample holder shown in Figures 1 and 2 in operation, Figure 3 being on a reduced scale;
  • Figure 4 is a flow chart describing a method for dissolution testing according to the invention.
  • Figure 1 shows an exploded isometric view of an in vitro dissolution test sample holder 10 according to the invention.
  • Sample holder 10 comprises a tubular body 12 having opposed open ends 14 and 16, a ring 18 and an end cap 20.
  • End cap 20 has a peripheral side wall 22 coaxially interengagable with the body 12 at open end 14 , and a flange 24 which extends substantially perpendicularly inwardly to define an aperture 26 through the end of the end cap. Cylindrical and circular shapes for the body, ring, end cap and apertures are preferred for ease of manufacture and assembly of the holder 10.
  • Flange 24 forms a support surface 28 within the end cap to support a porous membrane 30 which is placed within the end cap in overlying relation covering aperture 26.
  • the diameter of aperture 26 is smaller than the inner diameter of body 12 to provide a membrane support surface of practical size.
  • Ring 18 interfits coaxially within end cap 20 on top of membrane 30, the membrane being sandwiched between ring 18 and support surface 28 as seen in the cross- sectional view of Figure 2.
  • Synthetic membranes having pore sizes on the order of 0.45 microns have been found useful in dissolution testing although membranes of natural material, such as skin harvested from laboratory animals are also contemplated.
  • End cap 20 removably interengages tubular body 12, the end cap being retained to the tubular body, preferably by a friction or interference fit between the peripheral side wall 22 and the tubular body. It is preferred to have end cap 20 receive the body 12 as shown in Figure 2 allowing the cap to be manually gripped and easily removed from the body.
  • the frictional interengagement between side wall 22 and body 12 forms a seal keeping liquid receptor media out of the body when the holder is immersed as described below. Frictional interengagement of the end cap and the body eliminates the need for 0-rings and other types of seals, thus, simplifying the design of the holder.
  • the tubular body has an end surface 32 at open end 14 which engages ring 18 and compresses it against the membrane 30.
  • the membrane is, thus, clamped between flange 24 and ring 18 by the compressive force between the end cap and the tubular body.
  • Ring 18 has an inner perimeter 34 which is preferably sized and shaped to match the size and shape of aperture 26 as shown in Figure 2.
  • the ring also has a predetermined thickness 36. As best seen in Figure 2, the thickness 36 and perimeter 34 define a sample holding volume 38 where a sample 40 of the formulation to be tested is placed.
  • sample cover 42 is provided to prevent the sample from evaporating and leaving a residue during testing. Evaporation is a concern for example, during dissolution testing at elevated temperatures, or during tests of long duration.
  • sample cover 42 comprises a disk 44 which is sized and shaped to easily fit coaxially within tubular body 12 and seat on top of ring 18 completely covering the holding volume 38.
  • the sample cover has a handle 46 to facilitate manual placing of the sample cover into the tubular body.
  • Figure 4 is a flow chart which describes a method of dissolution testing according to the invention. Briefly described, the method steps include providing the various components comprising the test sample holder, assembling the components, loading the membrane with the test sample, mounting the holder on a rotatable shaft, immersing the end cap into a receptor media, agitating the media by rotating the holder, periodically measuring the concentration of the test sample in the receptor media and determining the rate of dissolution or drug release from the concentration measurements. These steps are described in more detail below.
  • the membrane 30 is placed within end cap 20 on support surface 28 completely covering aperture 26. Ring 18 is then placed within end cap 20 on membrane 30.
  • the end cap is interengaged with the open end 14 of tubular body 12, the peripheral side wall 22 receiving and engaging the tubular body 12 forming a seal and the tubular body end surface 32 engaging and compressing ring 18 against the membrane.
  • Sample material 40 is then loaded into the holding volume 38 through the opposite open end 16 of body 12.
  • the sample may be visually checked through open end 16 of body 12 to ensure that it completely covers the portion of membrane 30 beneath the holding volume 38 without any air pockets or other voids.
  • the sample cover 42 is placed within the tubular body 12 after visual inspection. The sample cover seats against ring 18 and prevents evaporation of the sample during the test.
  • the assembled sample holder 10, loaded with test sample material 40 is mounted on the end of a shaft 48 which is rotatably mounted on an armature 50 shown in Figure 3.
  • armature 50 shown in Figure 3.
  • open end 16 of body 12 receives the shaft, the shaft and the body interfitting in a friction or interference fit which retains the body to the shaft, yet allows it to be easily manually removed without the need for tools and separate fasteners. This affords a simple design, which is easy to use and requires few parts.
  • the sample holder 10 is mounted on the end of rotatable shaft 48 and positioned with end cap 20 immersed in a liquid receptor media 52 contained within a vessel 54.
  • Vessel 54 is itself immersed in a liquid bath 56 used to control the temperature of the receptor media 52.
  • receptor media 52 is a phosphate buffered aqueous solution having a pH which is set to simulate the conditions under which the sample will be used to dermally and/or transdermally deliver a drug or other therapeutic agent.
  • Aperture 26 (see Figure 2) exposes the side 30a of membrane 30 opposite the sample material 40 to the receptor media 52.
  • sample holder 10 can be rotated on shaft 48 by armature 50 at a predetermined rate to agitate the receptor media and further promote dissolution by maintaining sink conditions.
  • the concentration of the drug or therapeutic agent in the media is measured.
  • the dissolution or drug release rate is then determined from these concentration measurements.
  • One method of determining the rate is by generating a curve depicting the functional relation of concentration versus time from these measurements, the slope of the curve providing the dissolution rate of the sample.
  • the volume of the receptor media 52 is sufficiently large to keep the receptor media in a sink condition, i.e., always having a very low concentration of the active agent so as not to affect the dissolution or release rate of the sample.
  • the sample holder 10 is made of a chemically stable material such as Teflon® (PTFE) , stainless steel or titanium so that it will not react with the sample material or the receptor media and adversely affect the dissolution testing. It is advantageous to fabricate all of the components from the same material so that all of the parts have the same coefficient of thermal expansion. This will ensure that the parts fit together in the same relationship and maintain friction fits regardless of the temperature of the sample holder. If stainless steel or titanium is used, it is desirable to coat any points of contact between parts with Teflon® to facilitate assembly of the parts by allowing them to slide easily over one another.
  • PTFE Teflon®
  • Arranging the sample holder with the membrane 30 at the bottom ensures that the sample material 40 will be in contact with the membrane during the testing and, thus, be available to diffuse through the membrane and dissolve in the receptor media 52. It is expected that this configuration will provide for accurate, reproducible test results with a minimum of undesired variability between tests. This is especially important for testing lotions or oils which have a relatively low viscosity as compared with creams, gels or pastes. Lotions or oils would tend to run and separate from the membrane if the sample holder were in any other orientation. Thus, not all of the sample would be available for dissolving in the receptor media, adversely affecting the test results.
  • the use of the ring 18 to hold the membrane 30 in place provides a distinct advantage over other sample holders by allowing the sample holder according to the invention to be easily assembled without damaging the membrane.
  • Membranes tend to be delicate and easily torn, wrinkled or punctured when inserted into the sample holder. It is especially difficult to assemble sample holders in which the membrane is clamped between two parts which move relatively to one another, such as a screw cap on the end of a cylinder.
  • sample holder is completely assembled before any sample is introduced into it. This allows the sample material 40 to be visually inspected after it is placed in the sample holding volume 38 to ensure that the material is in contact with the entire membrane beneath the holding volume, and there are no air bubbles trapped against the membrane forming an occlusion. This is unlike other sample holders in which the sample material is placed into a part of the holder which is then joined to another part, effectively blocking all access to the sample material. Allowing visual inspection of the sample material prior to the test will help ensure accurate and repeatable test results with variability reduced to a minimum.
  • the in vitro test sample holder according to the invention is expected to provide an improved device for dissolution testing of topical formulations for the dermal and/or transdermal delivery of drugs or other therapeutic agents. Its configuration and construction are specifically designed to avoid the problems and disadvantages associated with devices currently used for dissolution and/or release testing and should result in more accurate and reliable test results.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Water Supply & Treatment (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A dissolution test sample holder (10) for testing topical formulations for dermal and/or transdermal drug delivery is disclosed. The holder (10) has a cylindrical tubular body (12) with an end cap (22) removably attached to one end (14). The end cap (22) has a peripheral wall (20) which frictionally engages the body (12) to hold the end cap (22) in place. A flange (24) extends perpendicularly from the peripheral wall (20) inwardly defining an aperture (26) in the end cap (22) and providing a support surface (28) for a membrane (30) held within the end cap (22). A ring (18) is positioned within the end cap (22) on the membrane (30), the membrane (30) being sandwiched between the ring (18) and the support surface (28). The ring (18) protects the membrane (30) by preventing contact between it and the body (12), and provides a volume for holding the test sample in contact with the membrane (30).

Description

DISSOLUTION TEST SAMPLE HOLDER
Field of the Invention
This invention is a device for holding a test sample during dissolution and/or release testing and is especially suited for holding viscous topical formulations used for transdermal and dermal drug delivery.
Background of the Invention
Topical formulations, including ointments, creams, lotions, pastes, oils and gels, are used in the dermal and transdermal (through the skin) delivery of active drugs such as, for example, hydrocortisone and nitroglycerin to sites of action in the body.
Topical application of a drug is advantageous because it allows localized delivery of the therapeutic agent directly to the desired site, thus, increasing bioavailability (the extent to which a drug reaches its site of action) , reducing drug side effects and loss of therapeutic efficiency and increasing patient compliance.
An important parameter in the development of dermal and transdermal drug delivery formulations is the rate at which the active drug is delivered. This parameter is measured in vitro (literally "in glass", meaning in the laboratory as opposed to in the living body) by drug release and/or dissolution testing. The United States Pharmacopeia specifies FDA approved standards for equipment and procedures used for dissolution testing.
It has been convention that a sample of the formulation, be it a cream, lotion, ointment, gel or other medium containing the drug or active agent, is placed on one side of a permeable membrane which simulates the barrier, presented by the skin, between the drug and the site of action. The membrane could be formed from actual skin taken from a laboratory animal, or a synthetic material such as polysulfone, acrylic polymer, glass fiber or PTFE to cite a few examples. The side of the membrane opposite the test sample is brought into contact with a liquid receptor media, and the drug or other active agent in the formulation diffuses through the membrane and dissolves into the receptor media. The concentration of the drug in the receptor media is measured periodically over time to establish the rate at which it is delivered into the media, thus, providing an indication of its delivery rate in actual use.
There are various devices currently available to hold the test sample during dissolution testing, and all of them suffer from one or more serious disadvantages. For example, some of the devices are complicated, having many interfitting parts which can be difficult and tedious to assemble. Assembly must be done by experienced technicians using great care to avoid puncturing, tearing or wrinkling the delicate membranes held in the devices. The devices are often loaded with the test sample before they are fully assembled, thus, preventing simple visual checks from being performed after assembly to ensure that the proper quantity of sample has been loaded and that the entire membrane surface is covered by the sample. In use, the devices are typically fully immersed in the vessel holding the receptor media with the membrane located facing upward at the top of the device. In this configuration, gravity works to pull the test sample out of contact with the membrane, air pockets can form adjacent to the membrane preventing contact between sample and membrane and causing variability of test measurements. This configuration also results in a "dead volume" of the receptor media forming under the device, the media in the "dead volume" being stagnant and not participating in the dissolution of the sample and, thus, being a source of inaccuracy in the measurements .
Clearly, there is a need for an improved test sample holder for dissolution testing which is simple in construction, is easy to assemble, minimizes the potential for damage to the membrane, allows for visual observation of the test sample, avoids the creation of dead volumes of receptor media or air pockets and is useable with standard United States Pharmacopeia dissolution equipment and procedures. Summary and Objects of the Invention
The invention is a dissolution test sample holder immersible within a liquid for measuring the release or dissolution rate of a test sample in the liquid. The test sample is dispensed into the liquid by diffusion through a porous membrane mounted within the holder.
The holder is formed by a tubular body having opposed ends, at least one of the ends being open. An end cap is removably attached to the open end. The end cap has a peripheral side wall coaxially interengaged with the body. Frictional forces between the side wall and the body hold the end cap removably to the body. An interference fit between the end cap and the body causes the friction and results in a seal between the side wall and the body. A flange extends substantially perpendicularly inwardly of the side wall and forms a surface within the end cap for supporting the porous membrane, the flange surrounding and defining an aperture through the end cap. The membrane is positionable on the surface and covers the aperture. The test sample is positionable within the end cap on the membrane.
The end of the body to which the end cap is attached is immersible to bring the membrane into contact with the liquid, thereby allowing the test sample to diffuse though the porous membrane and dissolve in the liquid.
When particularly delicate or thin membranes are to be used, it is preferable to include a ring sized to fit coaxially within the end cap. The ring is positioned on top of the membrane, the membrane being sandwiched between the ring and the support surface. The ring has a predetermined thickness and an inner perimeter defining a volume holding the test sample in contact with the membrane. When the holder is assembled, the body frictionally interfits within the end cap side wall and has an end surface engaging the ring and clamping the membrane between the ring and the support surface. The ring protects the delicate membrane from tearing or wrinkling by preventing direct contact between the body and the membrane.
In the preferred embodiment of the test sample holder, the tubular body and the end cap are cylindrical in shape, the aperture is circular and has a predetermined diameter, and the ring has circular inner and outer perimeters. In this embodiment, the ring inner diameter is substantially equal to the diameter of the aperture. This helps confine the test sample to the wetted area of the membrane, thus, ensuring that all of the sample is available for dissolution into the liquid. Varying the ring inner diameter as well as the ring thickness allows the volume of the test sample to be controlled as desired within the size limits of the end cap and body. In order to provide a membrane support surface of practical size, the end cap aperture diameter is smaller than an inner diameter of the body.
Due to its construction, the test sample holder according to the invention allows the test sample to be loaded after the holder has been assembled. This provides an opportunity to visually inspect the loaded holder and ensure that the correct amount of sample has been loaded, that there are no air bubbles or other voids in the sample diminishing the membrane wetted surface and that the membrane has not been damaged by the assembly or loading of the holder.
It is sometimes necessary to take steps to prevent the test sample from evaporating during the dissolution testing. Evaporation of the test sample will cause inaccurate test results and should be avoided. Evaporation may be caused when the test is conducted at elevated temperatures or when the test duration is long due to low dissolution rates. To prevent evaporation, a sample cover is used. The sample cover is formed by a disk having a diameter sized to slidingly interfit coaxially within the body and seat on the ring. When seated, the disk covers the test sample held within the inner perimeter of the ring.
It is desired to provide agitation of the liquid in the vicinity of the membrane to promote mixing of the test sample to maintain sink conditions (i.e., always having a very low concentration of the active agent) . Agitation is provided by having an opening in the body at the opposite end from the end cap, the opening being sized to accept a rotatable shaft in frictional interengagement . Preferably, the shaft is coaxial with the body and rotates it with the end cap end immersed within the liquid to promote dissolution of the test sample into the liquid.
The invention is used in a method of dissolution and/or release testing of a test sample in a liquid. Preferably, the method comprises the steps of:
(a) providing a tubular body having opposed open ends;
(b) providing an end cap removably attachable to one of the ends, the end cap having a peripheral side wall coaxially interengagable with the body and a flange extending substantially perpendicularly inwardly of the side wall and forming a support surface within the end cap, the flange surrounding and defining an aperture through the end cap; (c) providing a porous membrane positionable within the end cap on the support surface and covering the aperture;
(d) positioning the membrane on the support surface covering the aperture;
(e) attaching the end cap to the one end of the body by engaging the body with the peripheral wall;
(f) loading the test sample onto the membrane through the opposite open end of the body;
(g) immersing the one end of the body into the liquid thereby wetting said membrane; and
(h) measuring the concentration of the test sample in the liquid periodically.
When necessitated by the use of a thin or delicate membrane, the method also includes the steps of:
(i) providing a ring sized to fit coaxially within the end cap contiguous with the membrane, the ring having a predetermined thickness and an inner perimeter defining a volume holding the test sample in contact with the membrane;
(j) positioning the ring on the membrane coaxially within the end cap before the body and the end cap are interengaged, the membrane being sandwiched between the support surface and the ring.
When the ring is used, the loading step comprises loading the test sample onto the membrane within the inner perimeter of the ring.
When it is desired to agitate the liquid to promote dissolution the following steps are also included:
(k) attaching the other end of the tubular body (the end opposite from the end cap) coaxially to a rotatable shaft; and (1) rotating the body while the one end is immersed in the liquid to promote dissolution of the test sample.
It is an object of the invention to proved a dissolution test sample holder which will allow accurate measurements of the dissolution and/or release rate of a test sample to be taken.
It is another object of the invention to provide a test sample holder which will provide consistent and repeatable dissolution and/or release rates of a test sample with a minimum of test variability.
It is a further object of the invention to provide a test sample holder which is easy to assemble and load with the test sample.
It is yet another object of the invention to provide a test sample holder wherein the test sample is exposed to the entire wetted surface of the membrane.
It is still another object of the invention to provide a test sample holder wherein the test sample diffuses through the membrane by gravity.
It is again another object of the invention to provide a test sample holder wherein the volume of the test sample can be easily varied.
It is a further object of the invention to provide a test sample holder capable of using delicate membranes without damaging them.
It is again a further object of the invention to provide a test sample holder wherein the test sample can be visually inspected after the holder has been assembled and the test sample has been loaded.
It is yet another object of the invention to provide a test sample holder which can be rotated to provide agitation to promote the dissolution of the test sample. It is again another object of the invention to provide a test sample holder which can be used with standard dissolution equipment and procedures as specified in the United States Pharmacopeia.
It is a further objective of the invention to provide a method for using a test sample holder according to the invention to accurately, reliably, and repeatably measure the dissolution and/or release rate of a test sample.
These and other objects can be discerned from a consideration of the following drawings and detailed description of the invention.
Brief Description of the Drawings
Figure 1 is an exploded perspective view of a test sample holder according to the invention;
Figure 2 is a cross sectional side view of the test sample holder shown in Figure 1, the holder being shown assembled and on an enlarged scale;
Figure 3 is a side view of the test sample holder shown in Figures 1 and 2 in operation, Figure 3 being on a reduced scale; and
Figure 4 is a flow chart describing a method for dissolution testing according to the invention.
Detailed Description of the Preferred Embodiment
Figure 1 shows an exploded isometric view of an in vitro dissolution test sample holder 10 according to the invention. Sample holder 10 comprises a tubular body 12 having opposed open ends 14 and 16, a ring 18 and an end cap 20.
End cap 20 has a peripheral side wall 22 coaxially interengagable with the body 12 at open end 14 , and a flange 24 which extends substantially perpendicularly inwardly to define an aperture 26 through the end of the end cap. Cylindrical and circular shapes for the body, ring, end cap and apertures are preferred for ease of manufacture and assembly of the holder 10.
Flange 24 forms a support surface 28 within the end cap to support a porous membrane 30 which is placed within the end cap in overlying relation covering aperture 26. The diameter of aperture 26 is smaller than the inner diameter of body 12 to provide a membrane support surface of practical size. Ring 18 interfits coaxially within end cap 20 on top of membrane 30, the membrane being sandwiched between ring 18 and support surface 28 as seen in the cross- sectional view of Figure 2. Synthetic membranes having pore sizes on the order of 0.45 microns have been found useful in dissolution testing although membranes of natural material, such as skin harvested from laboratory animals are also contemplated.
End cap 20 removably interengages tubular body 12, the end cap being retained to the tubular body, preferably by a friction or interference fit between the peripheral side wall 22 and the tubular body. It is preferred to have end cap 20 receive the body 12 as shown in Figure 2 allowing the cap to be manually gripped and easily removed from the body. The frictional interengagement between side wall 22 and body 12 forms a seal keeping liquid receptor media out of the body when the holder is immersed as described below. Frictional interengagement of the end cap and the body eliminates the need for 0-rings and other types of seals, thus, simplifying the design of the holder.
The tubular body has an end surface 32 at open end 14 which engages ring 18 and compresses it against the membrane 30. The membrane is, thus, clamped between flange 24 and ring 18 by the compressive force between the end cap and the tubular body.
Ring 18 has an inner perimeter 34 which is preferably sized and shaped to match the size and shape of aperture 26 as shown in Figure 2. The ring also has a predetermined thickness 36. As best seen in Figure 2, the thickness 36 and perimeter 34 define a sample holding volume 38 where a sample 40 of the formulation to be tested is placed.
A sample cover 42 is provided to prevent the sample from evaporating and leaving a residue during testing. Evaporation is a concern for example, during dissolution testing at elevated temperatures, or during tests of long duration. Preferably, sample cover 42 comprises a disk 44 which is sized and shaped to easily fit coaxially within tubular body 12 and seat on top of ring 18 completely covering the holding volume 38. The sample cover has a handle 46 to facilitate manual placing of the sample cover into the tubular body.
Figure 4 is a flow chart which describes a method of dissolution testing according to the invention. Briefly described, the method steps include providing the various components comprising the test sample holder, assembling the components, loading the membrane with the test sample, mounting the holder on a rotatable shaft, immersing the end cap into a receptor media, agitating the media by rotating the holder, periodically measuring the concentration of the test sample in the receptor media and determining the rate of dissolution or drug release from the concentration measurements. These steps are described in more detail below. To assemble the sample holder 10 according to the invention, the membrane 30 is placed within end cap 20 on support surface 28 completely covering aperture 26. Ring 18 is then placed within end cap 20 on membrane 30. The end cap is interengaged with the open end 14 of tubular body 12, the peripheral side wall 22 receiving and engaging the tubular body 12 forming a seal and the tubular body end surface 32 engaging and compressing ring 18 against the membrane. Sample material 40 is then loaded into the holding volume 38 through the opposite open end 16 of body 12. The sample may be visually checked through open end 16 of body 12 to ensure that it completely covers the portion of membrane 30 beneath the holding volume 38 without any air pockets or other voids. If desired, the sample cover 42 is placed within the tubular body 12 after visual inspection. The sample cover seats against ring 18 and prevents evaporation of the sample during the test.
As seen in Figure 2 , the assembled sample holder 10, loaded with test sample material 40, is mounted on the end of a shaft 48 which is rotatably mounted on an armature 50 shown in Figure 3. Preferably, open end 16 of body 12 receives the shaft, the shaft and the body interfitting in a friction or interference fit which retains the body to the shaft, yet allows it to be easily manually removed without the need for tools and separate fasteners. This affords a simple design, which is easy to use and requires few parts.
As seen in Figure 3, the sample holder 10 is mounted on the end of rotatable shaft 48 and positioned with end cap 20 immersed in a liquid receptor media 52 contained within a vessel 54. Vessel 54 is itself immersed in a liquid bath 56 used to control the temperature of the receptor media 52. Preferably, receptor media 52 is a phosphate buffered aqueous solution having a pH which is set to simulate the conditions under which the sample will be used to dermally and/or transdermally deliver a drug or other therapeutic agent. Aperture 26 (see Figure 2) exposes the side 30a of membrane 30 opposite the sample material 40 to the receptor media 52. Care must be taken not to trap air against the membrane during immersion of the end cap, as it is preferable that the entire exposed membrane surface 30a be wetted by and in contact with the receptor media 52 to promote the dissolution and/or release of the active agent within the test sample 40 into the receptor media 52. If required, sample holder 10 can be rotated on shaft 48 by armature 50 at a predetermined rate to agitate the receptor media and further promote dissolution by maintaining sink conditions.
As the drug or other therapeutic agent diffuses through the membrane and dissolves in the receptor media 52, a portion of the receptor media is removed from vessel 54 periodically and the concentration of the drug or therapeutic agent in the media is measured. The dissolution or drug release rate is then determined from these concentration measurements. One method of determining the rate is by generating a curve depicting the functional relation of concentration versus time from these measurements, the slope of the curve providing the dissolution rate of the sample. Preferably, the volume of the receptor media 52 is sufficiently large to keep the receptor media in a sink condition, i.e., always having a very low concentration of the active agent so as not to affect the dissolution or release rate of the sample. Preferably, the sample holder 10 is made of a chemically stable material such as Teflon® (PTFE) , stainless steel or titanium so that it will not react with the sample material or the receptor media and adversely affect the dissolution testing. It is advantageous to fabricate all of the components from the same material so that all of the parts have the same coefficient of thermal expansion. This will ensure that the parts fit together in the same relationship and maintain friction fits regardless of the temperature of the sample holder. If stainless steel or titanium is used, it is desirable to coat any points of contact between parts with Teflon® to facilitate assembly of the parts by allowing them to slide easily over one another.
Arranging the sample holder with the membrane 30 at the bottom ensures that the sample material 40 will be in contact with the membrane during the testing and, thus, be available to diffuse through the membrane and dissolve in the receptor media 52. It is expected that this configuration will provide for accurate, reproducible test results with a minimum of undesired variability between tests. This is especially important for testing lotions or oils which have a relatively low viscosity as compared with creams, gels or pastes. Lotions or oils would tend to run and separate from the membrane if the sample holder were in any other orientation. Thus, not all of the sample would be available for dissolving in the receptor media, adversely affecting the test results.
Furthermore, by suspending and rotating the sample holder in vessel 54, all of the receptor media 52 will be available as a solvent, thus, eliminating stagnant "dead zones" of receptor media where effective mixing of solvent and solute does not occur. Dead zones in receptor media 52 are undesirable because they may lead to erroneous test results. Calculations of the concentration are based upon the entire volume of receptor media, but if there is a dead zone, an unknown and unquantifiable part of that volume is not participating in the test. This will introduce error into the test results.
The use of the ring 18 to hold the membrane 30 in place provides a distinct advantage over other sample holders by allowing the sample holder according to the invention to be easily assembled without damaging the membrane. Membranes tend to be delicate and easily torn, wrinkled or punctured when inserted into the sample holder. It is especially difficult to assemble sample holders in which the membrane is clamped between two parts which move relatively to one another, such as a screw cap on the end of a cylinder. By gently placing ring 18 on top of membrane 30 before placing end cap 20 onto the end of tubular body 12, the membrane is protected from any relative movement between the cap and its mating part, the tubular body.
Another advantage secured by the invention is that the sample holder is completely assembled before any sample is introduced into it. This allows the sample material 40 to be visually inspected after it is placed in the sample holding volume 38 to ensure that the material is in contact with the entire membrane beneath the holding volume, and there are no air bubbles trapped against the membrane forming an occlusion. This is unlike other sample holders in which the sample material is placed into a part of the holder which is then joined to another part, effectively blocking all access to the sample material. Allowing visual inspection of the sample material prior to the test will help ensure accurate and repeatable test results with variability reduced to a minimum.
The in vitro test sample holder according to the invention is expected to provide an improved device for dissolution testing of topical formulations for the dermal and/or transdermal delivery of drugs or other therapeutic agents. Its configuration and construction are specifically designed to avoid the problems and disadvantages associated with devices currently used for dissolution and/or release testing and should result in more accurate and reliable test results.

Claims

CLAIMSWhat is claimed is:
1. A dissolution test sample holder immersible within a liquid for measuring the dissolution or release rate of a test sample in said liquid, said holder comprising: a tubular body having opposed ends, one of said ends being open; an end cap removably attached to said one end, said end cap having a peripheral side wall coaxially interengaged with said body and a flange extending substantially perpendicularly inwardly of said side wall and forming a support surface within said end cap, said flange surrounding and defining an aperture through said end cap; a porous membrane positioned within said end cap on said support surface and covering said aperture; a ring sized to fit coaxially within said end cap contiguous with said membrane, said membrane being sandwiched between said support surface and said ring, said ring having a predetermined thickness and an inner perimeter defining a volume holding said test sample in contact with said membrane; said one end of said body being immersible to bring said membrane into contact with said liquid, said test sample passing though said porous membrane upon immersion and dissolving in said liquid.
2. A dissolution test sample holder according to Claim 1, wherein said tubular body and said end cap are cylindrical in shape, said aperture is circular and has a predetermined diameter, and said ring has circular inner and outer perimeters.
3. A dissolution test sample holder according to Claim 2 , wherein said end cap is removably attached to said body by friction between said side wall and said body.
4. A dissolution test sample holder according to Claim 3, wherein said body forms a seal with said end cap side wall.
5. A dissolution test sample holder according to Claim 3, wherein said ring has an inner diameter substantially equal to said aperture diameter and said aperture diameter is smaller than an inner diameter of said body.
6. A dissolution test sample holder according to Claim 5, further comprising a sample cover formed by a disk having a diameter sized to slidingly interfit coaxially within said body and seat on said ring, said disk covering said test sample held within said inner perimeter of said ring on said membrane.
7. A dissolution test sample holder according to Claim 5, wherein said body has another open end opposite said one end, said other open end being sized to accept a rotatable shaft in frictional interengagement, said shaft being coaxial with and rotating said body with said one end immersed within said liquid to promote dissolution of said test sample into said liquid.
8. A dissolution test sample holder according to Claim 5, wherein said tubular body has an end surface positioned at said one end engaging said ring, said end surface compressing said ring and clamping said membrane between said ring and said support surface.
9. A dissolution test sample holder immersible within a liquid for measuring the dissolution or release rate of a test sample in said liquid, said test sample being dispensed into said liquid through a porous membrane mounted within said holder, said holder comprising: a tubular body having opposed ends, at least one of said ends being open; an end cap removably attached to said one end, said end cap having a peripheral side wall coaxially interengaged with said body and a flange extending substantially perpendicularly inwardly of said side wall and forming a surface within said end cap for supporting said membrane, said flange surrounding and defining an aperture through said end cap, said membrane being positionable on said surface covering said aperture, said test sample being positionable within said end cap on said membrane; said one end of said body being immersible to bring said membrane into contact with said liquid, said test sample passing though said porous membrane upon immersion and dissolving in said liquid.
10. A dissolution test sample holder according to Claim 9, further comprising a ring sized to fit coaxially within said end cap on top of said membrane, said ring having a predetermined thickness and an inner perimeter defining a volume holding said test sample in contact with said membrane.
11. A dissolution test sample holder according to Claim 10, wherein said tubular body and said end cap are cylindrical in shape, said aperture is circular and has a predetermined diameter, and said ring has circular inner and outer perimeters.
12. A dissolution test sample holder according to Claim 11, wherein said one end of said body frictionally interfits within said end cap side wall and is contiguous with said ring, said ring preventing contact between said body and said membrane.
13. A dissolution test sample holder according to Claim 12 , wherein said ring has an inner diameter substantially equal to said aperture diameter and said aperture diameter is smaller than an inner diameter of said body.
14. A dissolution test sample holder according to Claim 13 , wherein the other of said ends is open and is sized to accept a rotatable shaft in frictional interengagement, said shaft being coaxial with and rotating said body with said one end immersed within said liquid to promote, dissolution of said test sample into said liquid.
15. A method of dissolution testing a test sample in a liquid, said method comprising the steps of: providing a tubular body having opposed ends, at least one of said ends b ing open; providing an end cap removably attachable to said one end, said end cap having a peripheral side wall coaxially interengagable with said body and a flange extending substantially perpendicularly inwardly of said side wall and forming a support surface within said end cap, said flange surrounding and defining an aperture through said end cap; providing a porous membrane positionable within said end cap on said support surface and covering said aperture; positioning said membrane on said support surface covering said aperture; loading said test sample onto said membrane; attaching said end cap to said one end of said body; immersing said one end of said body into said liquid thereby wetting said membrane; and measuring the concentration of said test sample in said liquid periodically.
16. A method of dissolution testing according to Claim 15, further including the steps of: providing a ring sized to fit coaxially within said end cap contiguous with said membrane, said ring having a predetermined thickness and inner perimeter defining a volume holding said test sample in contact with said membrane; positioning said ring on said membrane coaxially within said end cap, said membrane being sandwiched between said support surface and said ring; and wherein said loading step comprises loading said test sample onto said membrane within said inner perimeter of said ring.
17. A method of dissolution testing according to Claim 16, wherein the other end of said tubular body is open, said steps positioning said ring and attaching said end cap occur before said loading step, and said loading step comprises loading said test sample onto said membrane through said other open end.
18. A method of dissolution testing according to Claim 17 , further including the steps of attaching said other end of said tubular body coaxially to a rotatable shaft, and rotating said body while said one end is immersed in said liquid to promote dissolution of said test sample.
PCT/US2000/003003 1999-02-05 2000-02-04 Dissolution test sample holder WO2000046597A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU38562/00A AU3856200A (en) 1999-02-05 2000-02-04 Dissolution test sample holder
US09/890,484 US6929782B1 (en) 1999-02-05 2000-02-04 Dissolution test sample holder

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11882799P 1999-02-05 1999-02-05
US60/118,827 1999-02-05

Publications (2)

Publication Number Publication Date
WO2000046597A1 true WO2000046597A1 (en) 2000-08-10
WO2000046597A9 WO2000046597A9 (en) 2001-07-26

Family

ID=22380974

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/003003 WO2000046597A1 (en) 1999-02-05 2000-02-04 Dissolution test sample holder

Country Status (2)

Country Link
AU (1) AU3856200A (en)
WO (1) WO2000046597A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1455187A1 (en) * 2003-03-05 2004-09-08 Labonord Device for filtering and transfering particles
WO2006047076A1 (en) * 2004-10-21 2006-05-04 Cytyc Corporation Reduced aperture biological specimen collection and transfer device
US9733254B2 (en) 2012-10-04 2017-08-15 The University Of Bath Methods and apparatus for the in vitro modelling of drug administration
WO2021093979A1 (en) * 2019-11-15 2021-05-20 Nanopharm Limited In vitro release testing (ivrt) device for orally inhaled drug products
US20210247287A1 (en) * 2020-02-12 2021-08-12 National Guard Health Affairs In vitro dissolution test method for fluticasone propionate and other inhaled drugs

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3801280A (en) * 1971-11-11 1974-04-02 Upjohn Co Solubility-dissolution test apparatus and method
US3802272A (en) * 1973-01-24 1974-04-09 Dow Chemical Co Automatic dissolution rate determinator
US4464340A (en) * 1981-06-15 1984-08-07 Burroughs Wellcome Co. Dissolution flask
US4578244A (en) * 1982-04-23 1986-03-25 Pharmacontrol Corp. Sampling apparatus for obtaining a plurality of fluid samples
US4856909A (en) * 1986-06-23 1989-08-15 Rorer Pharmaceutical Corporation Pharmacological dissolution method and apparatus
US5011662A (en) * 1983-03-04 1991-04-30 Akbar Noormohammadi Dissolution testing machine
US5108710A (en) * 1990-11-26 1992-04-28 Little Amy C Transdermal patch holder
US5407567A (en) * 1993-11-01 1995-04-18 Newhard; Harry W. Compartmentalized swimming pool chemical dispenser
US5412979A (en) * 1993-05-03 1995-05-09 Temple University - Of The Commonwealth System Of Higher Education Method and apparatus for dissolution testing of a dosage form
US5476116A (en) * 1994-10-18 1995-12-19 Rainbow Lifegard Products, Inc. Floating adjustable pool chlorinator
US5589649A (en) * 1994-02-25 1996-12-31 Distek, Inc. Dissolution testing apparatus
US5816701A (en) * 1996-04-22 1998-10-06 Source For Automation, Inc. Automated tablet dissolution apparatus

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3801280A (en) * 1971-11-11 1974-04-02 Upjohn Co Solubility-dissolution test apparatus and method
US3802272A (en) * 1973-01-24 1974-04-09 Dow Chemical Co Automatic dissolution rate determinator
US4464340A (en) * 1981-06-15 1984-08-07 Burroughs Wellcome Co. Dissolution flask
US4578244A (en) * 1982-04-23 1986-03-25 Pharmacontrol Corp. Sampling apparatus for obtaining a plurality of fluid samples
US5011662A (en) * 1983-03-04 1991-04-30 Akbar Noormohammadi Dissolution testing machine
US4856909A (en) * 1986-06-23 1989-08-15 Rorer Pharmaceutical Corporation Pharmacological dissolution method and apparatus
US5108710A (en) * 1990-11-26 1992-04-28 Little Amy C Transdermal patch holder
US5412979A (en) * 1993-05-03 1995-05-09 Temple University - Of The Commonwealth System Of Higher Education Method and apparatus for dissolution testing of a dosage form
US5407567A (en) * 1993-11-01 1995-04-18 Newhard; Harry W. Compartmentalized swimming pool chemical dispenser
US5589649A (en) * 1994-02-25 1996-12-31 Distek, Inc. Dissolution testing apparatus
US5476116A (en) * 1994-10-18 1995-12-19 Rainbow Lifegard Products, Inc. Floating adjustable pool chlorinator
US5816701A (en) * 1996-04-22 1998-10-06 Source For Automation, Inc. Automated tablet dissolution apparatus

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1455187A1 (en) * 2003-03-05 2004-09-08 Labonord Device for filtering and transfering particles
WO2006047076A1 (en) * 2004-10-21 2006-05-04 Cytyc Corporation Reduced aperture biological specimen collection and transfer device
US7507578B2 (en) 2004-10-21 2009-03-24 Cytyc Corporation Reduced aperture biological specimen collection and transfer device
US9733254B2 (en) 2012-10-04 2017-08-15 The University Of Bath Methods and apparatus for the in vitro modelling of drug administration
WO2021093979A1 (en) * 2019-11-15 2021-05-20 Nanopharm Limited In vitro release testing (ivrt) device for orally inhaled drug products
CN114868019A (en) * 2019-11-15 2022-08-05 纳米制药有限公司 In Vitro Release Testing (IVRT) device for oral inhalation of pharmaceutical products
JP2023509570A (en) * 2019-11-15 2023-03-09 ナノファーム リミテッド In Vitro Release Testing (IVRT) Device for Oral Inhalation Formulations
JP7427781B2 (en) 2019-11-15 2024-02-05 ナノファーム リミテッド In vitro release testing (IVRT) device for oral inhalation formulations
US12078628B2 (en) 2019-11-15 2024-09-03 Nanopharm Limited In vitro release testing (IVRT) device for orally inhaled drug products
US20210247287A1 (en) * 2020-02-12 2021-08-12 National Guard Health Affairs In vitro dissolution test method for fluticasone propionate and other inhaled drugs
US11499904B2 (en) * 2020-02-12 2022-11-15 National Guard Health Affairs In vitro dissolution test method for fluticasone propionate and other inhaled drugs

Also Published As

Publication number Publication date
AU3856200A (en) 2000-08-25
WO2000046597A9 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
US6929782B1 (en) Dissolution test sample holder
US4594884A (en) Diffusion measuring device
Friend In vitro skin permeation techniques
Olejnik et al. Active compounds release from semisolid dosage forms
US4667504A (en) Flow through device for determination of the penetration rate of chemicals across biological membranes in vitro
JP2002514755A (en) Cartridge for electrochemical analysis
US20060260421A1 (en) Dissolution tester
ZA200508728B (en) Static diffusion cell for diffusion sampling systems
JP2011502623A (en) Transdermal body fluid sampling and pretreatment apparatus and method
US20060207356A1 (en) Dosage form holder device and methods for immersion testing
JP2011506934A (en) Dissolution test apparatus and method for testing
JP6763400B2 (en) Toilet bowl, method for measuring components in stool sample, method for stabilizing components in stool sample, and method for storing stool sample
EP2251691A1 (en) Method for analyzing sample solution and apparatus for analyzing sample solution
WO2000046597A1 (en) Dissolution test sample holder
US8647295B2 (en) Method for use of microdialysis
US10613011B2 (en) Diffusion cells and related methods
JP3349248B2 (en) Flow type corneal permeation test equipment and experimental equipment using this test equipment
JPS6073346A (en) Method and device for measuring speed of dissolution
Jug et al. In vitro dissolution/release methods for mucosal delivery systems
US4798207A (en) Device for enabling time-integrated measurement of substances in biological fluids
KR20010006499A (en) Method and device for determining adhesive performance of flat adhesive products on the skin of humans or mammals
KR101781741B1 (en) Test apparatus for material diffusion and the test method using thereof
US20020143244A1 (en) In-vivo blood storage system
WO1990015995A1 (en) Method and apparatus for the determination of glycosylated protein
EP3295167B1 (en) Method for determining release rates of active principle ingredients from at least one semisolid form

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/3-3/3, DRAWINGS, REPLACED BY NEW PAGES 1/3-3/3; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09890484

Country of ref document: US

122 Ep: pct application non-entry in european phase